Aspen Pharmacare Holdings Limited (OTCMKTS:APNHY) Short Interest Update

Aspen Pharmacare Holdings Limited (OTCMKTS:APNHYGet Rating) saw a significant decrease in short interest in April. As of April 30th, there was short interest totalling 300 shares, a decrease of 25.0% from the April 15th total of 400 shares. Based on an average daily volume of 1,000 shares, the short-interest ratio is currently 0.3 days.

Separately, Zacks Investment Research upgraded Aspen Pharmacare from a “strong sell” rating to a “hold” rating in a report on Tuesday.

Shares of OTCMKTS:APNHY opened at $9.81 on Wednesday. Aspen Pharmacare has a 1 year low of $9.60 and a 1 year high of $18.79. The business has a fifty day simple moving average of $11.94 and a 200 day simple moving average of $13.15. The company has a current ratio of 1.96, a quick ratio of 1.13 and a debt-to-equity ratio of 0.28.

Aspen Pharmacare Company Profile (Get Rating)

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand.

Further Reading

Receive News & Ratings for Aspen Pharmacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Pharmacare and related companies with MarketBeat.com's FREE daily email newsletter.